PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER
7 H1B filings at Accenture in FY2017
7
Total Filings
$177,400
Median Salary
100.0%
Approval Rate
7
Certified (0 denied)
Salary Distribution
Range shows where 80% of salaries fall. The marker indicates the median.
Range: $177,400 - $177,400
Salary Frequency
Hover over bars to see exact counts. Salary ranges in $25K increments.
Work Locations
CHADDS FORD, PA
1 filings
EDISON, NJ
1 filings
FLORHAM PARK, NJ
1 filings
LEXINGTON, MA
1 filings
NEW YORK, NY
1 filings
All Filings (7)
| Job Title | Location | Salary | Year | Status | View |
|---|---|---|---|---|---|
| PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER 15-1121 | Florham Park, NJ | $177,400 | FY2017 | CERTIFIED | View |
| PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER 15-1121 | North Wales, PA | $177,400 | FY2017 | CERTIFIED | View |
| PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER 15-1121 | Edison, NJ | $177,400 | FY2017 | CERTIFIED | View |
| PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER 15-1121 | New York, NY | $177,400 | FY2017 | CERTIFIED | View |
| PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER 15-1121 | Chadds Ford, PA | $177,400 | FY2017 | CERTIFIED | View |
| PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER 15-1121 | Washington, DC | $177,400 | FY2017 | CERTIFIED | View |
| PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER 15-1121 | Lexington, MA | $177,400 | FY2017 | CERTIFIED | View |
PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER CERTIFIED
Florham Park, NJ $177,400 FY2017
PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER CERTIFIED
North Wales, PA $177,400 FY2017
PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER CERTIFIED
Edison, NJ $177,400 FY2017
PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER CERTIFIED
New York, NY $177,400 FY2017
PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER CERTIFIED
Chadds Ford, PA $177,400 FY2017
PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER CERTIFIED
Washington, DC $177,400 FY2017
PHARMACEUTICAL R AND D PHARMACOVIGILANCE MANAGER CERTIFIED
Lexington, MA $177,400 FY2017